SCHEMBL3154207

SCHEMBL3154207

CCOC(C#N)(OCC)P(=O)(O)O

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.32
ALDH1A1 P00352 1/20 0.32
ACHE P22303 1/20 0.32
FDPS P14324 2/20 0.32
PPARD Q03181 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18486439 0.67 LMNA (0.39) TSHRFDPSPPARD
SCHEMBL98484 0.67 LMNA (0.39) FDPS
SCHEMBL13186023 0.67 LMNA (0.39) TSHRALDH1A1FDPSPPARD
SCHEMBL18486646 0.65 FDPS (0.36) TSHRFDPSPPARD
SCHEMBL29155304 0.65 FDPS (0.36) FDPS
SCHEMBL8878747 0.64 FDPS (0.31) TSHRFDPS
SCHEMBL11151927 0.64 FDPS (0.34) FDPS
SCHEMBL27783191 0.64 FDPS (0.40) FDPS
SCHEMBL5887949 0.63
SCHEMBL4835941 0.62 FDPS (0.33) FDPSPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116888101-A Substituted isoxazoline derivatives 巴斯夫欧洲公司 2023-10-13 CN disclosed
US-8076325-B2 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2011-12-13 US disclosed
EP-2036892-B1 1,2,4,5-tetrahydro-3H-benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2010-03-10 EP disclosed
WO-2009066041-A2 DERIVATIVES OF 1,2,4,5-TETRAHYDRO-3H-BENZAZEPINES, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2009-05-28 WO disclosed
EP-2036892-A1 1,2,4,5-tetrahydro-3H-benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2009-03-18 EP disclosed
US-20090069296-A1 1,2,4,5-Tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2009-03-12 US disclosed
US-4273713-A ANTIULCER AND ANTISECRETORY AGENTS STERLING DRUG INC. (US) 1981-06-16 US disclosed
US-4259338-A Benzofuranyl-tetrahydropyridines and -piperidines, their acid addition salts and antidepressant preparations thereof CIBA-GEIGY CORPORATION (US) 1981-03-31 US disclosed
US-4239687-A 4-CARBOXAMIDES, 4-THIOCARBOXAMIDES, 4-NITRILES, ANTISECRETORY, ANTIULCER STERLING DRUG INC. (US) 1980-12-16 US disclosed
US-4140854-A ANTISECRETORY, ANTIULCER STERLING DRUG INC. (US) 1979-02-20 US disclosed
US-4098797-A ANTISECRETORY, ANTIULCER AGENTS STERLING DRUG INC. (US) 1978-07-04 US disclosed
US-4008250-A ANTISECRETORY, ANTIULCER STERLING DRUG INC. (US) 1977-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069296-A1 1,2,4,5-Tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them OXER1, NR1H3, OXSR1 TSHR 268/4885ALDH1A1 1056/4885ACHE 2167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.